Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-03

Clinical Trial Update: Liposomal Bupivacaine Versus Non-liposomal Bupivacaine for Total Shoulder Arthroplasty [Phase 3]

View source ↗

Summary

Phase 3 trial comparing liposomal bupivacaine to non-liposomal bupivacaine for analgesia in total shoulder arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: University of Virginia | Conditions: Analgesia | Phase 3 | Status: COMPLETED